National Kidney Federation (NKF) - logo
 
GoTo home page (img 3K)
Conf 2004 Home Page (img 3K)
Contact the NKF

Text Only version

Ethics - Payment for Donor Organs

Please note, this page is a summary of the full conference speech (click here for the full transcript).

Dr Michael Wilkes

Dr Wilkes is chairman of the BMA Medical Ethics Committee and chairman of the Transplant Partnership, a wide-ranging coalition of professional and patient groups set up to campaign for a radical review of the organ donation system. In July this year he was elected a chief officer of the BMA. He had agreed to speak about the continuing crisis in organ transplantation and the ethics surrounding the sale of organs. Dr Wilkes reviewed the latest figures on organ donation. The statistics on donors dying in intensive care were static and there was as yet no answer to finding out why the refusal rate by relatives was so high. The new £6bn revamp of computers in the NHS National Programme Information Technology presumed that patients would like their information held on records unless you opted out.

Michael Wilkes,  8K


The Transplant Partnership had been really important and the input of the NKF, particularly Tim’s sterling efforts, had been extremely helpful. It had achieved its aim of getting legislation around organ donation. What next?

I think at the very least some of the arguments about how terrible selling organs is do not really stand up. Now the BMA would go no further than to say let’s at least discuss it. The first objection that is raised is of course the one of exploitation the familiar picture is of the first world preying on the third world and grabbing their organs, usually they are not much good. They usually need taking out again when these people get home again adding therefore to the load on the NHS.

The second big argument is that we destroy the concept of altruism, but the concept of a gift is not getting us too many organs at the moment. I think the arguments for a kind of discriminatory sort of economic pressure in this would largely disappear if we were to consider the concept of a regulated market in which there was a price for that organ. A kind of hidden exploitation is a real problem and one that I don’t have an answer for and I don’t think anybody else does because we have not really engaged in the debate.

Maybe the final issue is that we have an obligation to stop people making bad decisions. I find that rather paternalistic! I find it quite offensive for people to tell me that I couldn’t do this because it would be a bad decision.

 

Please note, this page is a summary of the full conference speech (click here for the full transcript).

Next >>GoTo Michelle HarrisMichelle Harris - Patient Speaker


The National Kidney Federation cannot accept responsibility for information provided. The above is for guidance only. Patients are advised to seek further information from their own doctor.



new NKF logoThe National Kidney Federation is registered in England and Wales as a Company limited by guarantee (Company No 5272349) and awarded charitable status (Charity Number 1106735). Give as You Earn contributions No. CAF GY511.

Registered Office:- The Point, Coach Road, Shireoaks, Worksop, Notts S81 8BW, Tel: (01909) 544999, Fax: (01909) 481723, Helpline: (0845) 601 02 09, E-mail: click here to E-mail Follow us on twitter

Union Flag This website is intended for UK residents only.
If you have any comments about this site, please EMAIL the webmaster

Page created: 27 February 2005

Last updated: 29 April 2009